Cidara Therapeutics
CDTX
CDTX
60 hedge funds and large institutions have $54.8M invested in Cidara Therapeutics in 2018 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 15 increasing their positions, 11 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
60
Holders Change
+12
Holders Change %
+25%
% of All Funds
1.38%
Holding in Top 10
3
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-40%
% of All Funds
0.07%
New
20
Increased
15
Reduced
11
Closed
8
Calls
$867K
Puts
$15K
Net Calls
+$852K
Net Calls Change
+$852K
Top Buyers
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
+$1.42M |
| 2 |
BlackRock
New York
|
+$725K |
| 3 |
GC
Guggenheim Capital
Chicago,
Illinois
|
+$483K |
| 4 |
Goldman Sachs
New York
|
+$409K |
| 5 |
Renaissance Technologies
New York
|
+$330K |
Top Sellers
| 1 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$5.44M |
| 2 |
BC
Broadfin Capital
New York
|
-$1.93M |
| 3 |
PVI
Pura Vida Investments
New York
|
-$1.87M |
| 4 |
PM
Prosight Management
Dallas,
Texas
|
-$1.85M |
| 5 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$1.17M |
